These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30275015)

  • 1. Codon usage regulates human KRAS expression at both transcriptional and translational levels.
    Fu J; Dang Y; Counter C; Liu Y
    J Biol Chem; 2018 Nov; 293(46):17929-17940. PubMed ID: 30275015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare codons regulate KRas oncogenesis.
    Lampson BL; Pershing NL; Prinz JA; Lacsina JR; Marzluff WF; Nicchitta CV; MacAlpine DM; Counter CM
    Curr Biol; 2013 Jan; 23(1):70-5. PubMed ID: 23246410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation bias within oncogene families is related to proliferation-specific codon usage.
    Benisty H; Weber M; Hernandez-Alias X; Schaefer MH; Serrano L
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30848-30856. PubMed ID: 33199641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type Kras expands and exhausts hematopoietic stem cells.
    Sasine JP; Himburg HA; Termini CM; Roos M; Tran E; Zhao L; Kan J; Li M; Zhang Y; de Barros SC; Rao DS; Counter CM; Chute JP
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A code within the genetic code: codon usage regulates co-translational protein folding.
    Liu Y
    Cell Commun Signal; 2020 Sep; 18(1):145. PubMed ID: 32907610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare codons capacitate Kras-driven de novo tumorigenesis.
    Pershing NL; Lampson BL; Belsky JA; Kaltenbrun E; MacAlpine DM; Counter CM
    J Clin Invest; 2015 Jan; 125(1):222-33. PubMed ID: 25437878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codon Usage Influences the Local Rate of Translation Elongation to Regulate Co-translational Protein Folding.
    Yu CH; Dang Y; Zhou Z; Wu C; Zhao F; Sachs MS; Liu Y
    Mol Cell; 2015 Sep; 59(5):744-54. PubMed ID: 26321254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synonymous but Not Silent: The Codon Usage Code for Gene Expression and Protein Folding.
    Liu Y; Yang Q; Zhao F
    Annu Rev Biochem; 2021 Jun; 90():375-401. PubMed ID: 33441035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread position-specific conservation of synonymous rare codons within coding sequences.
    Chaney JL; Steele A; Carmichael R; Rodriguez A; Specht AT; Ngo K; Li J; Emrich S; Clark PL
    PLoS Comput Biol; 2017 May; 13(5):e1005531. PubMed ID: 28475588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon usage is an important determinant of gene expression levels largely through its effects on transcription.
    Zhou Z; Dang Y; Zhou M; Li L; Yu CH; Fu J; Chen S; Liu Y
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6117-E6125. PubMed ID: 27671647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
    Huang L; Counter CM
    PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synonymous Codon Usage-a Guide for Co-Translational Protein Folding in the Cell].
    Komar AA
    Mol Biol (Mosk); 2019; 53(6):883-898. PubMed ID: 31876270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synonymous codon usage regulates translation initiation.
    Barrington CL; Galindo G; Koch AL; Horton ER; Morrison EJ; Tisa S; Stasevich TJ; Rissland OS
    Cell Rep; 2023 Dec; 42(12):113413. PubMed ID: 38096059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
    Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
    Netzel BC; Grebe SK
    Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codon usage regulates protein structure and function by affecting translation elongation speed in Drosophila cells.
    Zhao F; Yu CH; Liu Y
    Nucleic Acids Res; 2017 Aug; 45(14):8484-8492. PubMed ID: 28582582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Codon Usage on Protein Structure and Folding.
    Moss MJ; Chamness LM; Clark PL
    Annu Rev Biophys; 2024 Jul; 53(1):87-108. PubMed ID: 38134335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.
    Yin G; Kistler S; George SD; Kuhlmann N; Garvey L; Huynh M; Bagni RK; Lammers M; Der CJ; Campbell SL
    J Biol Chem; 2017 Mar; 292(11):4446-4456. PubMed ID: 28154176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
    Wei Y; Wang F; Sang B; Xu Z; Yang D
    Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D.
    Johnson CW; Lin YJ; Reid D; Parker J; Pavlopoulos S; Dischinger P; Graveel C; Aguirre AJ; Steensma M; Haigis KM; Mattos C
    Cell Rep; 2019 Aug; 28(6):1538-1550.e7. PubMed ID: 31390567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.